Insights on Health Care
1338 total results. Page 1 of 54.
Pat Naples was quoted discussing the Centers for Medicare & Medicaid Services’ (CMS) planned launch of the Independent Dispute Resolution (IDR) Gateway, a new online platform intended to improve transparency and efficiency in the No Surprises Act (NSA) arbitration process.
Health care providers using skin substitutes now face a two-front enforcement campaign. On August 5, the US Attorney’s Office for the District of Nevada indicted physician Dr. Stephen Dubin on health care fraud charges, alleging a $95 million illegal kickback scheme to bill Medicare for medically unnecessary amniotic wound allografts.
The Texas Attorney General’s office recently announced a settlement of nearly $34 million with AstraZeneca Pharmaceuticals LP. The settlement resolves allegations that AstraZeneca violated the Texas Health Care Program Fraud Prevention Act (THFPA) — the state-law analog to the federal False Claims Act and Anti-Kickback Statute (AKS) — in connection with the sale of 17 of the company’s drugs.
In Sala v. Premier Imaging Holdings, LLC, 240 Conn. App. 793, 2026 WL 2220267 (Conn. App. Aug. 4, 2026), the Connecticut Appellate Court affirmed the trial court’s decision to overturn an arbitration award that had declared a physician noncompete “valid and binding,” because the arbitration award enforced a restrictive covenant that exceeded the one-year and 15-mile limits for physician noncompetes allowed under CT Gen Stat § 20-14p.
ArentFox Schiff is pleased to announce that 125 attorneys have been recognized by The Best Lawyers in America 2027, with two attorneys highlighted as “Lawyers of the Year” and 36 attorneys listed as “Ones to Watch.”
On August 11, out-of-network health care providers scored an important, although not complete, victory under the federal No Surprises Act (NSA) when the US Court of Appeals for the Fifth Circuit, sitting en banc, issued its decision in Texas Medical Association v. United States Department of Health and Human Services, No. 23-40605.
Health Care Practice Co-Leader Douglas Grimm was quoted on how the publicly traded health system Q2 financial reports are a barometer of the state of the current marketplace, as well as a sign of what is coming.
Health Care Practice Co-Leader Douglas Grimm was a featured guest on Competition Policy International, a PYMNTS company, to discuss how deregulating artificial intelligence (AI) for use in health care doesn’t necessarily remove barriers to the industry’s adoption.
On July 14, the US Food and Drug Administration (FDA) announced final guidance regarding clinical investigations of psychedelic drugs.
On June 26, Illinois Governor JB Pritzker signed House Bill 4517 into law, amending the Illinois Authorized Electronic Monitoring in Long-Term Care Facilities Act.
On July 2, the Centers for Medicare & Medicaid Services (CMS) released the Calendar Year 2027 Hospital Outpatient Prospective Payment System (OPPS) and Ambulatory Surgical Center (ASC) Proposed Rule (CMS-1850-P).
On July 16, the Centers for Medicare & Medicaid Services (CMS) published the 2027 Physician Fee Schedule (PFS) proposed rule. Among other provisions, CMS has now proposed to convert a previously voluntary filing to a mandatory submission: requiring 340B Covered Entities to submit Part D claims data to the Medicare Part D Claims Data 340B Repository beginning in 2027.
A newly filed California suit, Winters v. OpenAI, Inc. et al., may become the first case to test whether product liability and negligence per se theories can reach a generative artificial intelligence (AI) chatbot’s design and deployment decisions, after ChatGPT-4o’s health-related guidance allegedly contributed to a plaintiff’s near-fatal medical emergency.
Pat Naples was quoted on the results of the KFF Health Tracking Poll and the perception of the federal push behind health care fraud enforcement as a partisan issue.
Peptides remain one of the hottest topics in the drug industry, and many therapeutic peptides offered for sale today have been compounded.
Group Purchasing Organizations are no longer just negotiating prices — they’re increasingly helping hospitals navigate risk, volatility, and complexity with data and artificial intelligence (AI). AI-enabled models increasingly help hospitals, especially smaller, resource-constrained facilities stretch dollars and manage risk in a volatile supply chain environment.
Health Care Partner Anne M. Murphy and Practice Leader Douglas A. Grimm were quoted in Law360 discussing how health care transactional lawyers are increasingly taking on the role of strategic “producers,” coordinating legal, regulatory, communications, and stakeholder efforts to drive complex provider transactions forward.